Responsible Business
We believe that success is possible thanks to our commitment to transparency, ethics and a solid Corporate Governance. Therefore, we have policies and processes that safeguard the integrity of our operations, as well as the compliance with all laws and regulations in the countries in which we operate.
In addition, each member of our team shares the company's values, working with honesty, respect and responsibility, generating trust externally and internally with the objective of creating value for all stakeholders.
Corporate Governance
We work under the best market practices, considering the recommendations of the Mexican Stock Exchange, demonstrating our commitment to transparency to all our stakeholders.
Learn more: https://inversionistas.genommalab.com/en/corporate-governance/
Risk Management Course
We have developed a risk training program for all staff. This is with the aim of improving the capabilities of our collaborators so they can contribute to their identification, management and mitigation. This course aims to foster an organizational culture that values proactive risk management and promotes the participation of all members of the Company in the risk management process.
Integrity Policies
Our commitment is that in Genomma Lab there exists a culture of ethics and active communication, which allows us to have a work environment of trust and compliance based on corporate governance according to the best practices, standards and laws applicable in each country where we operate, by preventing unethical behavior and promoting a culture of legality both within the Company and in the relationship with our stakeholders.
Human Rights
We are committed to promoting, defending and monitoring the human rights of our collaborators and interest groups. Our operation is carried out within the framework of international standards and norms, including the Universal Declaration of Human Rights and the Declaration of the International Labor Organization (ILO), as well as the principles of the United Nations Global Compact, to which we adhere. . In response, during 2023 and early 2024, we updated our Due Diligence analysis, where we identified the main real and/or potential impacts that may occur in our operations, such as in the value chain. The methodology for identifying the main associated risks was based on the recommendations of the United Nations Guiding Principles on Business and Human Rights.
PDFEthical System “GEN- Te Escucha”
The Ethical System “GEN- Te Escucha” is a formal mechanism that can be used both by all the people who collaborate with Genomma Lab, in all the countries in which we operate, as well as by third parties with whom the Company has some relationship in the development of its operations.
We promote the identification and reporting of illegal acts, actual or potential breaches of our Code of Conduct and Ethics, Policies, Procedures and / or inappropriate conduct in our operations.
Visit the site: https://gen-teescucha.ethicsglobal.com/#modal
Ethics Committee
The Ethics Committee is the internal entity that supervises the correct compliance with each of the values and principles contained in our Code of Conduct and Ethics, integrity policies, applicable laws and the Gen Book.
Members of our Ethics Committe
- General Director
- Global Leader of Human Resources, Institutional Relations, Social Responsibility & Media
- Global Legal Leader
The Committee is responsible to receive, investigate and provide a solution to cases of non-compliance presented by employees, suppliers, business partners or members of the communities near our operation centers. It also proposes programs and actions within the Company in order to create an adequate working environment for the personal and organizational development of our employees.
Our Products
- We focus on offering products that improve the quality of life of our consumers, simultaneously integrating elements that have an environmental and social benefit.
- We aim to innovate in order to reduce the percentage of material used in the packaging of our products, in addition to using materials with a lower environmental impact, through alliances with our suppliers and commercial partners.
- We participate in courses and workshops to share good practices on issues related to the circular economy, eco-design, production and sustainable consumption.
For more information, consult our Sustainability Strategy 2025 PDF
Responsible Supply
We are committed to integrate sustainability in the management of our value chain, as a result our sustainability program for suppliers was created. Said program seeks to promote good practices, cooperation and continuous improvement among the members of our supply chain.
This program applies to our suppliers of raw materials, packaging material, maquilas (finished product) and transportation (logistics), in order to reduce any potential risk and strengthen our relationships of trust, honesty and integrity.
The program consists of 3 phases:
- Information: Read and sign the Code of Conduct and Ethics for Suppliers.
- Evaluation: Self-evaluation in Social Responsibility and Sustainability.
- Training
- Evaluation: Self-evaluation in Social Responsibility and Sustainability.
Local Suppliers
Since 2010, we have maintained a strategic partnership with La Joya del Campo S.A. de C.V., a community supplier. This supplier harvests and markets guayaba leaves (Psidium Guajava) in the Totonaca farming communities of Veracruz as part of its production model. Quercetin, is the active ingredient in our QG5® product to treat colitis, is obtained from this raw material.
During 2020, guayaba leaf production was reduced as a result of increased rainfall in the area, which is why, during 2021, we purchased a large volume (27 tons) of this raw material to supply production for the year and have a reserve in case of a possible shortage. For this reason, the volume of guayaba leaf purchased during 2022 was lower (9 tons). With this, we reaffirm our commitment to the economic development of Totonaca communities.
Animal Testing
We are a Mexican company, with presence in more than 18 countries in America, committed to promote legality, ethics, responsibility and the common wealth. We seek to offer products that improve the quality of life of our consumers, simultaneously integrating elements that have an environmental and social benefit.
For this reason, according to our Sustainability model, Integrity Policies, care and protection of biodiversity, we do NOT conduct tests or studies on animals to obtain data on the efficacy and safety of our products, and we promote the use of raw materials, materials and processes that are aligned with this condition.
According to our Sustainability Strategy 2025, we have implemented several actions to contribute to the care of the planet, mitigate climate change, promote the circular economy and reduce waste generation through prevention, reduction, recycling and reuse activities.
Tax Strategy
Corporate income tax is payable con the profits obtained by Genomma Lab Internacional, as provided by the tax laws in the countries we operate in.
Our aim is to pay the right amount of tax, at the right time, on the profits we generate, and in the countries where these are generated. We are commited not to transfer the created value to low tax jurisdictions. For this reason we have the following guidelines:
- We comply with the tax laws and regulations in each country where we operate, also considering the intention of the tax policy.
- In our operation we do not use tax structures that have the purpose of erode the taxable base.
- We do not make use of secret jurisdictions or so-called "tax havens".
Likewise, we comply with the applicable legislation regarding transfer pricing between our different subsidiaries, in the countries where we have a presence. It is the Audit and Corporate Practices Committee that issues a favorable opinion to submit to the Board of Directors the approval of the financial statements and, thereby, determine the applicable income and taxes paid in the different countries.